The global Leishmaniasis Treatment Market is supported by ongoing research into antiparasitic drugs and improved therapeutic approaches. Researchers are exploring treatment options that may improve efficacy, reduce adverse effects, and address challenges associated with existing medicines. The Leishmaniasis Treatment Market is expected to reach US$ 288.93 million by 2034 from US$ 196.84 million...